Insights into the Mn2+ Binding Site in the Agmatinase-Like Protein (ALP): A Critical Enzyme for the Regulation of Agmatine Levels in Mammals
Open Access
- 10 June 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (11), 4132
- https://doi.org/10.3390/ijms21114132
Abstract
Agmatine is a neurotransmitter with anticonvulsant, anti-neurotoxic and antidepressant-like effects, in addition it has hypoglycemic actions. Agmatine is converted to putrescine and urea by agmatinase (AGM) and by an agmatinase-like protein (ALP), a new type of enzyme which is present in human and rodent brain tissues. Recombinant rat brain ALP is the only mammalian protein that exhibits significant agmatinase activity in vitro and generates putrescine under in vivo conditions. ALP, despite differing in amino acid sequence from all members of the ureohydrolase family, is strictly dependent on Mn2+ for catalytic activity. However, the Mn2+ ligands have not yet been identified due to the lack of structural information coupled with the low sequence identity that ALPs display with known ureohydrolases. In this work, we generated a structural model of the Mn2+ binding site of the ALP and we propose new putative Mn2+ ligands. Then, we cloned and expressed a sequence of 210 amino acids, here called the “central-ALP”, which include the putative ligands of Mn2+. The results suggest that the central-ALP is catalytically active, as agmatinase, with an unaltered Km for agmatine and a decreased kcat. Similar to wild-type ALP, central-ALP is activated by Mn2+ with a similar affinity. Besides, a simple mutant D217A, a double mutant E288A/K290A, and a triple mutant N213A/Q215A/D217A of these putative Mn2+ ligands result on the loss of ALP agmatinase activity. Our results indicate that the central-ALP contains the active site for agmatine hydrolysis, as well as that the residues identified are relevant for the ALP catalysis.This publication has 47 references indexed in Scilit:
- Agmatine: clinical applications after 100 years in translationDrug Discovery Today, 2013
- Metformin can Activate Imidazoline I-2 Receptors to Lower Plasma Glucose in Type 1-like Diabetic RatsHormone and Metabolic Research, 2010
- Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brainAnatomy & Cell Biology, 2010
- Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generationAmerican Journal of Physiology-Renal Physiology, 2008
- Agmatine and Imidazoline Receptors: Their Role in Opioid Analgesia, Tolerance and DependenceCellular and Molecular Neurobiology, 2007
- Studies on the interaction of Escherichia coli agmatinase with manganese ions: structural and kinetic studies of the H126N and H151N variantsJournal of Inorganic Biochemistry, 2004
- A graph‐theory algorithm for rapid protein side‐chain predictionProtein Science, 2003
- Manganese Is Essential for Catalytic Activity ofEscherichia coliAgmatinaseBiochemical and Biophysical Research Communications, 1999
- Clonidine-Displacing Substance and Its Putative Role in Control of Insulin Secretion: A MinireviewGeneral Pharmacology: The Vascular System, 1998
- IMatriuresis following Central and Peripheral Administration of Agmatine in the RatPharmacology, 1996